Functional role of Meox2 during the epithelial cytostatic response to TGF-β

Molecular Oncology

Volumn 1, Issue 1, 2007, Pages 55-71

  Valcourt, Ulrich ^a   Thuault, Sylvie ^a   Pardali, Katerina ^a   Heldin, Carl Henrik ^a   Moustakas, Aristidis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell cycle; Epithelial mesenchymal transition; Homeobox; p21Cip1 Waf1; Signal transduction; Smad; Transcription; Transforming growth factor ; Tumor suppressor

Indexed keywords

HOMEODOMAIN PROTEIN; MESSENGER RNA; PROTEIN MEOX2; PROTEIN P21; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL PROLIFERATION; CYTOSTASIS; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; RESPONSE ELEMENTS; RNA INTERFERENCE; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34248671096     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2007.02.002     Document Type: Article

References (44)

1. Andrés V., Fisher S., Wearsch P., and Walsh K. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol. Cell. Biol. 15 (1995) 4272-4281
2. WAF1/CIP1 mediates the growth response to TGF-β in human epithelial cells. Cancer Biol. Ther. 3 (2004) 221-225
3. Candia A.F., Hu J., Crosby J., Lalley P.A., Noden D., Nadeau J.H., and Wright C.V. Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. Development 116 (1992) 1123-1136
4. WAF1/CIP1expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences. J. Biol. Chem. 282 (2007) 507-517
5. Cordenonsi M., Dupont S., Maretto S., Insinga A., Imbriano C., and Piccolo S. Links between tumor suppressors: p53 is required for TGF-β gene responses by cooperating with Smads. Cell 113 (2003) 301-314
6. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., and Wang X.-F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92 (1995) 5545-5549
7. Datto M.B., Yu Y., and Wang X.-F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270 (1995) 28623-28628
8. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55 (1995) 2910-2919
9. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
10. Gorski D.H., and Leal A.J. Inhibition of endothelial cell activation by the homeobox gene Gax. J. Surg. Res. 111 (2003) 91-99
11. Gorski D.H., LePage D.F., Patel C.V., Copeland N.G., Jenkins N.A., and Walsh K. Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol. Cell. Biol. 13 (1993) 3722-3733
12. Huber M.A., Kraut N., and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17 (2005) 548-558
13. Inman G.J., Nicolas F.J., and Hill C.S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF- β receptor activity. Mol. Cell 10 (2002) 283-294
14. Jin J.Z., and Ding J. Analysis of Meox-2 mutant mice reveals a novel postfusion-based cleft palate. Dev Dyn 235 (2006) 539-546
15. Kowanetz M., Valcourt U., Bergström R., Heldin C.-H., and Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to tranforming growth factor β and bone morphogenetic protein. Mol. Cell. Biol. 24 (2004) 4241-4254
16. Kurisaki K., Kurisaki A., Valcourt U., Terentiev A.A., Pardali K., ten Dijke P., Heldin C.-H., Ericsson J., and Moustakas A. Nuclear factor YY1 inhibits transforming growth factor β- and bone morphogenetic protein-induced cell differentiation. Mol. Cell. Biol. 23 (2003) 4494-4510
17. Maillard L., Van Belle E., Smith R.C., Le Roux A., Denéfle P., Steg G., Barry J.J., Branellec D., Isner J.M., and Walsh K. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc. Res. 35 (1997) 536-546
18. Mankoo B.S., Collins N.S., Ashby P., Grigorieva E., Pevny L.H., Candia A., Wright C.V., Rigby P.W., and Pachnis V. Mox2 is a component of the genetic hierarchy controlling limb muscle development. Nature 400 (1999) 69-73
19. Massagué J. How cells read TGF-β signals. Nat. Rev. Mol. Cell. Biol. 1 (2000) 169-178
20. Massagué J. G1 cell-cycle control and cancer. Nature 432 (2004) 298-306
21. Morén A., Imamura T., Miyazono K., Heldin C.-H., and Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J. Biol. Chem. 280 (2005) 22115-22123
22. Moustakas A., and Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95 (1998) 6733-6738
23. Moustakas A., Pardali K., Gaal A., and Heldin C.-H. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol. Lett. 82 (2002) 85-91
24. Nicolas F.J., and Hill C.S. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22 (2003) 3698-3711
25. WAF1/Cip1. J. Cell. Physiol. 204 (2005) 260-272
26. Waf1/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 275 (2000) 29244-29256
27. Pardali K., and Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775 (2007) 21-62
28. Patel S., Leal A.D., and Gorski D.H. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-κB-dependent endothelial cell gene expression. Cancer Res. 65 (2005) 1414-1424
29. Perlman H., Sata M., Le Roux A., Sedlak T.W., Branellec D., and Walsh K. Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J. 17 (1998) 3576-3586
30. Quinn L.M., Latham S.E., and Kalionis B. The homeobox genes MSX2 and MOX2 are candidates for regulating epithelial-mesenchymal cell interactions in the human placenta. Placenta 21 Suppl. A (2000) S50-S54
31. Rodrigo I., Bovolenta P., Mankoo B.S., and Imai K. Meox homeodomain proteins are required for Bapx1 expression in the sclerotome and activate its transcription by direct binding to its promoter. Mol. Cell. Biol. 24 (2004) 2757-2766
32. KIP1. J. Biol. Chem. 276 (2001) 40687-40692
33. Seoane J., Le H.V., Shen L., Anderson S.A., and Massagué J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 (2004) 211-223
34. Shi Y., and Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
35. Siegel P.M., and Massagué J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3 (2003) 807-820
36. Skopicki H.A., Lyons G.E., Schatteman G., Smith R.C., Andrés V., Schirm S., Isner J., and Walsh K. Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle. Circ. Res. 80 (1997) 452-462
37. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11 (1997) 1674-1689
38. ten Dijke P., Goumans M.-J., Itoh F., and Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191 (2002) 1-16
39. ten Dijke P., and Hill C.S. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29 (2004) 265-273
40. Thuault S., Valcourt U., Petersen M., Manfioletti G., Heldin C.-H., and Moustakas A. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174 (2006) 175-183
41. Valcourt U., Gouttenoire J., Moustakas A., Herbage D., and Mallein-Gerin F. Functions of transforming growth factor-β family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J. Biol. Chem. 277 (2002) 33545-33558
42. Valcourt U., Kowanetz M., Niimi H., Heldin C.-H., and Moustakas A. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16 (2005) 1987-2002
43. Witzenbichler B., Kureishi Y., Luo Z., Le Roux A., Branellec D., and Walsh K. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J. Clin. Invest. 104 (1999) 1469-1480
44. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., et al. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 11 (2005) 959-965